Income Statement for the Period, Consolidated (IFRS)
Gross Sales Revenues
10
0
CAGR
-2,5%
3Q13
10.5B
10494025
3Q14
10.7B
10705945
3Q15
11.9B
11925345
3Q16
8.70B
8698749
3Q17
9.48B
9476204
Assets, Consolidated (IFRS)
Total Assets
10
0
CAGR
-5,1%
3Q14
61.5B
61472407
3Q15
76.5B
76489683
3Q16
58.7B
58712707
3Q17
52.6B
52575446
Liabilities, Consolidated (IFRS)
Consolidated Stockholders' Equity
3
0
CAGR
-9,1%
3Q14
33.2B
33208206
3Q15
36.0B
36012381
3Q16
27.8B
27840946
3Q17
24.9B
24902616